NCT02587247View on ClinicalTrials.gov

ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

TF2 antibody/68Ga-IMP-288

TF2 antibody coupled with 68Ga-IMP-288

Trial Locations (2)

44093

CHU, Nantes

44805

Institut de cancérologie de l'Ouest, Saint-Herblain

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02587247 - ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer | Biotech Hunter | Biotech Hunter